IMS Maxims will now, in an exclusive deal, market the MetaVision Suite, a product range for critical care, perioperative and acute care units. The company will lead on sales, implementation and support actives for the Israel-based tech company.
The companies cite the move as part of a best-of-breed offering to trusts in the UK.
Shahar Sery, Executive Vice President, iMDsoft, commented on the news: “We are pleased to partner with IMS MAXIMS, a digital healthcare provider in the UK and Ireland. Our visions and values are closely aligned and we’re confident that through our channel partners programme, IMS MAXIMS will take great care of current and future MetaVision users.
“We look forward to working with IMS MAXIMS to deliver our advanced clinical information systems that will excite the region, advancing clinical safety, workflows, and efficiency.”
Thomas Anderson, CEO, IMS MAXIMS, added: “We’re really excited to have reached an agreement with iMDsoft as their distribution partner in the UK and Ireland. One of the things that has become very clear during the process has been our common values and focus on customer satisfaction and supporting them to deliver excellent patient care.
“MetaVision is completely complementary to the IMS MAXIMS solution and we look forward to exploring opportunities across our joint user base. We’re confident that this partnership will be very successful over the coming years and look forward to a bright future together.”
HTN last reported on news from iMDSoft in 2016, when the company announced that two new NHS trusts would adopt the solution.
